Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-target Effects with Reduced Off-tumor Toxicity for Use in Immuno-Oncology.

Autio KA, Boni V, Humphrey RW, Naing A.

Clin Cancer Res. 2019 Oct 10. pii: clincanres.1457.2019. doi: 10.1158/1078-0432.CCR-19-1457. [Epub ahead of print]

PMID:
31601568
2.

CCR 20th Anniversary Commentary: Immune-Related Response Criteria--Capturing Clinical Activity in Immuno-Oncology.

Hoos A, Wolchok JD, Humphrey RW, Hodi FS.

Clin Cancer Res. 2015 Nov 15;21(22):4989-91. doi: 10.1158/1078-0432.CCR-14-3128.

3.

Opportunities and challenges in the development of experimental drug combinations for cancer.

Humphrey RW, Brockway-Lunardi LM, Bonk DT, Dohoney KM, Doroshow JH, Meech SJ, Ratain MJ, Topalian SL, Pardoll DM.

J Natl Cancer Inst. 2011 Aug 17;103(16):1222-6. doi: 10.1093/jnci/djr246. Epub 2011 Jul 15.

4.

Recommended changes to oncology clinical trial design: revolution or evolution?

Ratain MJ, Humphrey RW, Gordon GB, Fyfe G, Adamson PC, Fleming TR, Stadler WM, Berry DA, Peck CC.

Eur J Cancer. 2008 Jan;44(1):8-11. Epub 2007 Nov 5. No abstract available.

5.

A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection.

Humphrey RW, Wyvill KM, Nguyen BY, Shay LE, Kohler DR, Steinberg SM, Ueno T, Fukasawa T, Shintani M, Hayashi H, Mitsuya H, Yarchoan R.

Antiviral Res. 1999 Feb;41(1):21-33.

PMID:
10321576
6.

Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.

Perno CF, Newcomb FM, Davis DA, Aquaro S, Humphrey RW, Caliò R, Yarchoan R.

J Infect Dis. 1998 Aug;178(2):413-22.

PMID:
9697721
7.

Human herpesvirus 8 (HHV-8) in the pathogenesis of Kaposi's sarcoma and other diseases.

Humphrey RW, Davis DA, Newcomb FM, Yarchoan R.

Leuk Lymphoma. 1998 Jan;28(3-4):255-64. Review.

PMID:
9517497
8.

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

Welles L, Saville MW, Lietzau J, Pluda JM, Wyvill KM, Feuerstein I, Figg WD, Lush R, Odom J, Wilson WH, Fajardo MT, Humphrey RW, Feigal E, Tuck D, Steinberg SM, Broder S, Yarchoan R.

J Clin Oncol. 1998 Mar;16(3):1112-21.

PMID:
9508198
9.

Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology.

Humphrey RW, Ohagen A, Davis DA, Fukazawa T, Hayashi H, Höglund S, Mitsuya H, Yarchoan R.

Antimicrob Agents Chemother. 1997 May;41(5):1017-23.

10.

Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.

Davis DA, Humphrey RW, Newcomb FM, O'Brien TR, Goedert JJ, Straus SE, Yarchoan R.

J Infect Dis. 1997 May;175(5):1071-9.

PMID:
9129068
11.

Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.

Humphrey RW, O'Brien TR, Newcomb FM, Nishihara H, Wyvill KM, Ramos GA, Saville MW, Goedert JJ, Straus SE, Yarchoan R.

Blood. 1996 Jul 1;88(1):297-301.

PMID:
8704186
12.

Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.

Davis DA, Branca AA, Pallenberg AJ, Marschner TM, Patt LM, Chatlynne LG, Humphrey RW, Yarchoan R, Levine RL.

Arch Biochem Biophys. 1995 Sep 10;322(1):127-34.

PMID:
7574666
13.

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel.

Saville MW, Lietzau J, Pluda JM, Feuerstein I, Odom J, Wilson WH, Humphrey RW, Feigal E, Steinberg SM, Broder S, et al.

Lancet. 1995 Jul 1;346(8966):26-8.

PMID:
7603142
14.

Identification and characterization of nonsedimentable lipid-protein microvesicles.

Yao K, Paliyath G, Humphrey RW, Hallett FR, Thompson JE.

Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2269-73.

15.

Mitochondrial and myocardial performance. Response to ischemia and reperfusion.

Weinstein ES, Spector ML, Adams EM, Yokum MD, Humphrey RW, Fry DE.

Arch Surg. 1986 Mar;121(3):324-9.

PMID:
3947230
16.

Correction of congenital duodenal obstruction assisted by intraoperative endoscopic guidance.

Humphrey RW, Dorazio R.

Gastrointest Endosc. 1984 Feb;30(1):46-7. No abstract available.

PMID:
6706092
17.

Supplemental Content

Loading ...
Support Center